In the present study, we designed the CH-based nanocarrier for co-delivery of DTX and IGF-1R siRNA, and subsequently, MUC1 Apt was conjugated to the NPs for evaluating cell viability and genes expression in metastatic breast cancer cells. This evidence concerns the gene MUC1 and breast carcinoma.